St. Marianna University School of Medicine;Kyowa Hakko Kirin Co., Ltd.
发明人:
申请号：
EP13813070.3
公开号：
EP2870973A1
申请日:
2013.07.03
申请国别(地区):
EP
年份:
2015
代理人:
摘要：
The object of the present invention is to provide a new therapeutic method and a new therapeutic agent that are different from known therapeutic medicines for human T cell leukemia virus type-1 associated myelopathy (HAM) patients and asymptomatic HTLV-1 carriers. The present invention relates to a therapeutic method and a therapeutic agent for human T cell leukemia virus type-1(HTLV-1) associated myelopathy (HAM) patients and asymptomatic HTLV-1 carriers (ACs), which is characterized by reducing HTLV-1 virus-infected cells using an anti-human CC-chemokine receptor 4 (CCR4) antibody.
